SLC2A1 and breast carcinoma: Importantly, we demonstrated that P-cadherin aberrant expression was significantly associated with the expression of HIF-1α, GLUT1, CAIX, MCT1, and CD147 in human primary invasive breast tumors, which is in line with the glycolytic phenotype of P-cadherin-enriched basal-like breast carcinomas [91].